MX2022008666A - Composicion probiotica para su uso como antioxidante. - Google Patents

Composicion probiotica para su uso como antioxidante.

Info

Publication number
MX2022008666A
MX2022008666A MX2022008666A MX2022008666A MX2022008666A MX 2022008666 A MX2022008666 A MX 2022008666A MX 2022008666 A MX2022008666 A MX 2022008666A MX 2022008666 A MX2022008666 A MX 2022008666A MX 2022008666 A MX2022008666 A MX 2022008666A
Authority
MX
Mexico
Prior art keywords
antioxidant
probiotic composition
rhamnosus
casei
longum
Prior art date
Application number
MX2022008666A
Other languages
English (en)
Inventor
Vidal Daniel Ramón
Martínez Salvador Genovés
Guerola Patricia Martorell
Cuadros Maria Empar Chenoll
Román Francisco Javier López
Ávila Gandía Vicente
García Fernando Cánovas
Original Assignee
Biopolis SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopolis SL filed Critical Biopolis SL
Publication of MX2022008666A publication Critical patent/MX2022008666A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

La presente invención se refiere a una composición probiótica que consiste en las bacterias Lactobacillus rhamnosus, Lactobacillus casei y Bifidobacterium longum, preferiblemente en las cepas L. rhamnosus CECT8361, L. casei CECT9104 y B. longum CECT7347, y a su uso como antioxidante. Esta composición es particularmente útil en el tratamiento y/o prevención del daño, a nivel molecular, provocado por el estrés oxidativo, preferiblemente durante la realización de un ejercicio físico de elevada intensidad.
MX2022008666A 2020-01-15 2021-01-14 Composicion probiotica para su uso como antioxidante. MX2022008666A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20382019.6A EP3851115A1 (en) 2020-01-15 2020-01-15 Probiotic composition for its use as an antioxidant
PCT/EP2021/050631 WO2021144333A1 (en) 2020-01-15 2021-01-14 Probiotic composition for use as an antioxidant

Publications (1)

Publication Number Publication Date
MX2022008666A true MX2022008666A (es) 2022-08-10

Family

ID=70482582

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022008666A MX2022008666A (es) 2020-01-15 2021-01-14 Composicion probiotica para su uso como antioxidante.

Country Status (10)

Country Link
US (1) US20230028548A1 (es)
EP (2) EP3851115A1 (es)
JP (1) JP2023514808A (es)
KR (1) KR20220127817A (es)
CN (1) CN115279385A (es)
AU (1) AU2021208431A1 (es)
CA (1) CA3162995A1 (es)
MX (1) MX2022008666A (es)
PL (1) PL4048299T3 (es)
WO (1) WO2021144333A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023111270A1 (en) * 2021-12-16 2023-06-22 Biopolis, S. L. Use of postbiotics in the treatment and/or prevention of anxiety disorders
CN116694528A (zh) * 2023-06-20 2023-09-05 广东南芯医疗科技有限公司 长双歧杆菌lf04在制备抗氧化和抗衰老产品中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101333505B (zh) 2007-06-26 2011-01-12 内蒙古农业大学 一种干酪乳杆菌在抗氧化作用方面的应用
ES2526986B1 (es) * 2013-07-18 2015-11-02 Biopolis, S.L. Nueva cepa de Bifidobacterium animalis subsp. lactis CECT 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas
CA2966487A1 (en) * 2014-11-06 2016-05-12 NWO Stem Cure, LLC Nutraceutical supplement with lactobacillus rhamnosus
ES2575828B1 (es) 2014-12-31 2017-07-07 Universidad De León Empleo de probióticos en el incremento de la fertilidad masculina
EP3222282A1 (en) * 2016-03-21 2017-09-27 Bionou Research, S.L. Use of probiotics in the treatment and/or prevention of psoriasis
EP3272396A1 (en) 2016-07-18 2018-01-24 Bionou Research, S.L. Use of probiotics in the treatment and/or prevention of atopic dermatitis
KR102069807B1 (ko) * 2017-03-09 2020-01-28 가톨릭대학교 산학협력단 유산균 혼합물을 포함하는 면역 질환의 예방 및 치료용 조성물
CN108157973B (zh) * 2017-12-14 2021-04-02 上海交通大学医学院附属瑞金医院 一种有益糖脂代谢功能的益生菌组合物及其制剂和应用
CN107927794A (zh) * 2017-12-20 2018-04-20 北京康比特体育科技股份有限公司 一种益生菌功能食品组合物及其制备方法
CA3091152A1 (en) * 2018-02-13 2019-08-22 Proviva Pharma Inc. Probiotic formulations for the treatment and alleviation of metabolic and oxidative stress, inflammation and neurodegeneration

Also Published As

Publication number Publication date
EP4048299C0 (en) 2024-01-03
US20230028548A1 (en) 2023-01-26
CA3162995A1 (en) 2021-07-22
AU2021208431A1 (en) 2022-06-16
EP4048299A1 (en) 2022-08-31
KR20220127817A (ko) 2022-09-20
PL4048299T3 (pl) 2024-04-22
EP4048299B1 (en) 2024-01-03
WO2021144333A1 (en) 2021-07-22
CN115279385A (zh) 2022-11-01
JP2023514808A (ja) 2023-04-11
EP3851115A1 (en) 2021-07-21

Similar Documents

Publication Publication Date Title
MX2022003373A (es) Composiciones a base de cepas bacterianas y su uso como antiinflamatorios.
UA111715C2 (uk) Композиція, що містить пробіотичні бактерії для застосування у лікуванні імунних розладів
KR20200065004A (ko) 클로스트리듐 디피실리 감염을 치료하기 위한 새로운 용도
MX2011012069A (es) Micro-organismos no-replicantes y su efecto inmuno estimulador.
AR086677A2 (es) Composicion de bacterias de acido lactico y su uso para hacer un suplemento alimentario de higiene o farmaceutica para la prevencion y/o tratamiento de infecciones y condiciones inflamatorias
MX2022003374A (es) Cepas bacterianas, sus composiciones y su uso para el tratamiento de trastornos gastrointestinales.
MX2022008666A (es) Composicion probiotica para su uso como antioxidante.
BR0213189A (pt) Composição compreendendo uma cepa lactobacillus pentosus e usos da mesma
EP4272815A3 (en) New medical use of probiotics
BR112019001116A2 (pt) composição probiótica usada no tratamento e/ou prevenção da dermatite atópica
MX2018002093A (es) Composicion y metodo para el tratamiento y profilaxis de infeccion e inflamacion intestinal.
HK1067985A1 (en) Lactic acid bacteria and their use for treating and preventing cancer
RU2010147343A (ru) ИЗОЛИРОВАННЫЙ ШТАММ МИКРООРГАНИЗМА Lactobacillus plantarum Inducia DSM 21379 В КАЧЕСТВЕ ПРОБИОТИКА, УСИЛИВАЮЩЕГО ВРОЖДЕННЫЙ ИММУНИТЕТ ОРГАНИЗМА, ПРОДУКТ И КОМПОЗИЦИЯ, СОДЕРЖАЩИЕ УПОМОМЯНУТЫЙ МИКРООРГАНИЗМ, И ПРИМЕНЕНИЕ УПОМЯНУТОГО МИКРООРГАНИЗМА ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА, КОТОРОЕ УСИЛИВАЕТ КЛЕТОЧНЫЙ ИММУНИТЕТ
BR112018069284A2 (pt) composição probiótica e seu uso no tratamento e/ou prevenção da psoríase
ITMI20051509A1 (it) Ceppi di bifidobacterium produttori di acido folico loro formulazioni e uso
MY151204A (en) Lactobacillus plantarum and uses thereof
AR063850A1 (es) Novedosa capa de lactobacillus fermentum, su uso, composicon farmaceutica y articulo sanitario que la comprenden y metodo para su preparacion
AR035761A1 (es) Bacterias de acido lactico como agentes para tratar y prevenir la alergia
MX2022003372A (es) Cepas bacterianas, sus composiciones y su uso para el tratamiento de trastornos gastrointestinales.
DE60237645D1 (de) Immunstimulierendes Mittel enthaltend eine Biomasse von methanotrophem Bakterium
MX2021009398A (es) Composiciones probioticas que comprenden cepas de lactobacillus reuteri y metodos de uso.
MX2018008857A (es) Cepa de bacteria probiotica novedosa de lactobacillus plantarum y composiciones y usos de esta en el tratamiento de inflamacion.
UA94056C2 (uk) Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій
ATE367821T1 (de) Folsäure produzierende bifidobacterium bakterienstämme, ihre formulierungen und verwendung
BR112022024128A2 (pt) Composição de microbiota vaginal, e, método para tratar uma infecção